+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Influenza Diagnostics Market 2024-2028

  • PDF Icon

    Report

  • 180 Pages
  • May 2024
  • Region: Global
  • TechNavio
  • ID: 5130921
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The influenza diagnostics market is forecasted to grow by USD 517.5 million during 2023-2028, accelerating at a CAGR of 7.22% during the forecast period. The report on the influenza diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising incidence of influenza, growing demand for molecular diagnostics, and supportive government initiatives and funding.

The influenza diagnostics market is segmented as below:

By End-user

  • Hospitals and diagnostic laboratories
  • Academic and research centers
  • Homecare

By Type

  • Point-of-care testing
  • Immunodiagnostics
  • Molecular diagnostics

By Geography

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the rising approvals for influenza diagnostic products as one of the prime reasons driving the influenza diagnostics market growth during the next few years. Also, surge in number of genetic characterization studies on influenza virus and rising adoption of rapid diagnostic products in physician office laboratories will lead to sizable demand in the market.

The report on the influenza diagnostics market covers the following areas:

  • Influenza diagnostics market sizing
  • Influenza diagnostics market forecast
  • Influenza diagnostics market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading influenza diagnostics market vendors that include Abbott Laboratories, Becton Dickinson and Co., BICO Group AB, Bio Rad Laboratories Inc., Biocartis NV, bioMerieux SA, Danaher Corp., DiaSorin SpA, F. Hoffmann La Roche Ltd., Hologic Inc., Princeton BioMeditech Corp., QIAGEN NV, Quidelortho Corp., Response Biomedical Corp., SA Scientific Ltd., Sd Biosensor Inc., Sekisui Chemical Co. Ltd., Siemens Healthineers AG, Tecan Trading AG, and Thermo Fisher Scientific Inc.. Also, the influenza diagnostics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market by Geography
Executive Summary - Chart on Market Segmentation by End-user
Executive Summary - Chart on Market Segmentation by Type
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis
3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ million)
Data Table on Global - Market size and forecast 2023-2028 ($ million)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global Influenza Diagnostics Market 2018 - 2022
Historic Market Size - Data Table on Global Influenza Diagnostics Market 2018 - 2022 ($ million)
4.2 End-user segment analysis 2018 - 2022
Historic Market Size - End-user Segment 2018 - 2022 ($ million)
4.3 Type segment analysis 2018 - 2022
Historic Market Size - Type Segment 2018 - 2022 ($ million)
4.4 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by End-user
6.1 Market segments
Chart on End-user - Market share 2023-2028 (%)
Data Table on End-user - Market share 2023-2028 (%)
6.2 Comparison by End-user
Chart on Comparison by End-user
Data Table on Comparison by End-user
6.3 Hospitals and diagnostic laboratories - Market size and forecast 2023-2028
Chart on Hospitals and diagnostic laboratories - Market size and forecast 2023-2028 ($ million)
Data Table on Hospitals and diagnostic laboratories - Market size and forecast 2023-2028 ($ million)
Chart on Hospitals and diagnostic laboratories - Year-over-year growth 2023-2028 (%)
Data Table on Hospitals and diagnostic laboratories - Year-over-year growth 2023-2028 (%)
6.4 Academic and research centers - Market size and forecast 2023-2028
Chart on Academic and research centers - Market size and forecast 2023-2028 ($ million)
Data Table on Academic and research centers - Market size and forecast 2023-2028 ($ million)
Chart on Academic and research centers - Year-over-year growth 2023-2028 (%)
Data Table on Academic and research centers - Year-over-year growth 2023-2028 (%)
6.5 Homecare - Market size and forecast 2023-2028
Chart on Homecare - Market size and forecast 2023-2028 ($ million)
Data Table on Homecare - Market size and forecast 2023-2028 ($ million)
Chart on Homecare - Year-over-year growth 2023-2028 (%)
Data Table on Homecare - Year-over-year growth 2023-2028 (%)
6.6 Market opportunity by End-user
Market opportunity by End-user ($ million)
Data Table on Market opportunity by End-user ($ million)
7 Market Segmentation by Type
7.1 Market segments
Chart on Type - Market share 2023-2028 (%)
Data Table on Type - Market share 2023-2028 (%)
7.2 Comparison by Type
Chart on Comparison by Type
Data Table on Comparison by Type
7.3 Point-of-care testing - Market size and forecast 2023-2028
Chart on Point-of-care testing - Market size and forecast 2023-2028 ($ million)
Data Table on Point-of-care testing - Market size and forecast 2023-2028 ($ million)
Chart on Point-of-care testing - Year-over-year growth 2023-2028 (%)
Data Table on Point-of-care testing - Year-over-year growth 2023-2028 (%)
7.4 Immunodiagnostics - Market size and forecast 2023-2028
Chart on Immunodiagnostics - Market size and forecast 2023-2028 ($ million)
Data Table on Immunodiagnostics - Market size and forecast 2023-2028 ($ million)
Chart on Immunodiagnostics - Year-over-year growth 2023-2028 (%)
Data Table on Immunodiagnostics - Year-over-year growth 2023-2028 (%)
7.5 Molecular diagnostics - Market size and forecast 2023-2028
Chart on Molecular diagnostics - Market size and forecast 2023-2028 ($ million)
Data Table on Molecular diagnostics - Market size and forecast 2023-2028 ($ million)
Chart on Molecular diagnostics - Year-over-year growth 2023-2028 (%)
Data Table on Molecular diagnostics - Year-over-year growth 2023-2028 (%)
7.6 Market opportunity by Type
Market opportunity by Type ($ million)
Data Table on Market opportunity by Type ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Chart on Market share By Geographical Landscape2023-2028 (%)
Data Table on Market share By Geographical Landscape2023-2028 (%)
9.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ million)
Data Table on North America - Market size and forecast 2023-2028 ($ million)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ million)
Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ million)
Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ million)
Data Table on US - Market size and forecast 2023-2028 ($ million)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 China - Market size and forecast 2023-2028
Chart on China - Market size and forecast 2023-2028 ($ million)
Data Table on China - Market size and forecast 2023-2028 ($ million)
Chart on China - Year-over-year growth 2023-2028 (%)
Data Table on China - Year-over-year growth 2023-2028 (%)
9.9 Germany - Market size and forecast 2023-2028
Chart on Germany - Market size and forecast 2023-2028 ($ million)
Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Chart on Germany - Year-over-year growth 2023-2028 (%)
Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.10 France - Market size and forecast 2023-2028
Chart on France - Market size and forecast 2023-2028 ($ million)
Data Table on France - Market size and forecast 2023-2028 ($ million)
Chart on France - Year-over-year growth 2023-2028 (%)
Data Table on France - Year-over-year growth 2023-2028 (%)
9.11 Canada - Market size and forecast 2023-2028
Chart on Canada - Market size and forecast 2023-2028 ($ million)
Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Chart on Canada - Year-over-year growth 2023-2028 (%)
Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity by geography
Market opportunity By Geographical Landscape($ million)
Data Tables on Market opportunity By Geographical Landscape($ million)
10 Drivers, Challenges, and Opportunity/Restraints
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
10.4 Market opportunities/restraints
11 Competitive Landscape
11.1 Overview
11.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
11.3 Landscape disruption
Overview on factors of disruption
11.4 Industry risks
Impact of key risks on business
12 Competitive Analysis
12.1 Companies profiled
Companies covered
12.2 Market positioning of companies
Matrix on companies position and classification
12.3 Abbott Laboratories
Abbott Laboratories - Overview
Abbott Laboratories - Business segments
Abbott Laboratories - Key news
Abbott Laboratories - Key offerings
Abbott Laboratories - Segment focus
12.4 Becton Dickinson and Co.
Becton Dickinson and Co. - Overview
Becton Dickinson and Co. - Business segments
Becton Dickinson and Co. - Key news
Becton Dickinson and Co. - Key offerings
Becton Dickinson and Co. - Segment focus
12.5 BICO Group AB
BICO Group AB - Overview
BICO Group AB - Business segments
BICO Group AB - Key news
BICO Group AB - Key offerings
BICO Group AB - Segment focus
12.6 Bio Rad Laboratories Inc.
Bio Rad Laboratories Inc. - Overview
Bio Rad Laboratories Inc. - Business segments
Bio Rad Laboratories Inc. - Key news
Bio Rad Laboratories Inc. - Key offerings
Bio Rad Laboratories Inc. - Segment focus
12.7 Biocartis NV
Biocartis NV - Overview
Biocartis NV - Product / Service
Biocartis NV - Key news
Biocartis NV - Key offerings
12.8 bioMerieux SA
bioMerieux SA - Overview
bioMerieux SA - Product / Service
bioMerieux SA - Key news
bioMerieux SA - Key offerings
12.9 Danaher Corp.
Danaher Corp. - Overview
Danaher Corp. - Business segments
Danaher Corp. - Key news
Danaher Corp. - Key offerings
Danaher Corp. - Segment focus
12.10 DiaSorin SpA
DiaSorin SpA - Overview
DiaSorin SpA - Business segments
DiaSorin SpA - Key news
DiaSorin SpA - Key offerings
DiaSorin SpA - Segment focus
12.11 F. Hoffmann La Roche Ltd.
F. Hoffmann La Roche Ltd. - Overview
F. Hoffmann La Roche Ltd. - Business segments
F. Hoffmann La Roche Ltd. - Key news
F. Hoffmann La Roche Ltd. - Key offerings
F. Hoffmann La Roche Ltd. - Segment focus
12.12 Hologic Inc.
Hologic Inc. - Overview
Hologic Inc. - Business segments
Hologic Inc. - Key news
Hologic Inc. - Key offerings
Hologic Inc. - Segment focus
12.13 Princeton BioMeditech Corp.
Princeton BioMeditech Corp. - Overview
Princeton BioMeditech Corp. - Product / Service
Princeton BioMeditech Corp. - Key offerings
12.14 Quidelortho Corp.
Quidelortho Corp. - Overview
Quidelortho Corp. - Product / Service
Quidelortho Corp. - Key news
Quidelortho Corp. - Key offerings
12.15 Sd Biosensor Inc.
Sd Biosensor Inc. - Overview
Sd Biosensor Inc. - Product / Service
Sd Biosensor Inc. - Key offerings
12.16 Siemens Healthineers AG
Siemens Healthineers AG - Overview
Siemens Healthineers AG - Business segments
Siemens Healthineers AG - Key news
Siemens Healthineers AG - Key offerings
Siemens Healthineers AG - Segment focus
12.17 Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. - Overview
Thermo Fisher Scientific Inc. - Business segments
Thermo Fisher Scientific Inc. - Key news
Thermo Fisher Scientific Inc. - Key offerings
Thermo Fisher Scientific Inc. - Segment focus
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
13.3 Currency conversion rates for US$
Currency conversion rates for US$
13.4 Research methodology
Research methodology
13.5 Data procurement
Information sources
13.6 Data validation
Data validation
13.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
13.8 Data synthesis
Data synthesis
13.9 360 degree market analysis
360 degree market analysis
13.10 List of abbreviations
List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market by Geography
Exhibits 5: Executive Summary - Chart on Market Segmentation by End-user
Exhibits 6: Executive Summary - Chart on Market Segmentation by Type
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Company Market Positioning
Exhibits 10: Parent Market
Exhibits 11: Data Table on - Parent Market
Exhibits 12: Market characteristics analysis
Exhibits 13: Value Chain Analysis
Exhibits 14: Offerings of companies included in the market definition
Exhibits 15: Market segments
Exhibits 16: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 17: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 20: Historic Market Size - Data Table on Global Influenza Diagnostics Market 2018 - 2022 ($ million)
Exhibits 21: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
Exhibits 22: Historic Market Size - Type Segment 2018 - 2022 ($ million)
Exhibits 23: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits 24: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits 25: Five forces analysis - Comparison between 2023 and 2028
Exhibits 26: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 28: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 29: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 30: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 31: Chart on Market condition - Five forces 2023 and 2028
Exhibits 32: Chart on End-user - Market share 2023-2028 (%)
Exhibits 33: Data Table on End-user - Market share 2023-2028 (%)
Exhibits 34: Chart on Comparison by End-user
Exhibits 35: Data Table on Comparison by End-user
Exhibits 36: Chart on Hospitals and diagnostic laboratories - Market size and forecast 2023-2028 ($ million)
Exhibits 37: Data Table on Hospitals and diagnostic laboratories - Market size and forecast 2023-2028 ($ million)
Exhibits 38: Chart on Hospitals and diagnostic laboratories - Year-over-year growth 2023-2028 (%)
Exhibits 39: Data Table on Hospitals and diagnostic laboratories - Year-over-year growth 2023-2028 (%)
Exhibits 40: Chart on Academic and research centers - Market size and forecast 2023-2028 ($ million)
Exhibits 41: Data Table on Academic and research centers - Market size and forecast 2023-2028 ($ million)
Exhibits 42: Chart on Academic and research centers - Year-over-year growth 2023-2028 (%)
Exhibits 43: Data Table on Academic and research centers - Year-over-year growth 2023-2028 (%)
Exhibits 44: Chart on Homecare - Market size and forecast 2023-2028 ($ million)
Exhibits 45: Data Table on Homecare - Market size and forecast 2023-2028 ($ million)
Exhibits 46: Chart on Homecare - Year-over-year growth 2023-2028 (%)
Exhibits 47: Data Table on Homecare - Year-over-year growth 2023-2028 (%)
Exhibits 48: Market opportunity by End-user ($ million)
Exhibits 49: Data Table on Market opportunity by End-user ($ million)
Exhibits 50: Chart on Type - Market share 2023-2028 (%)
Exhibits 51: Data Table on Type - Market share 2023-2028 (%)
Exhibits 52: Chart on Comparison by Type
Exhibits 53: Data Table on Comparison by Type
Exhibits 54: Chart on Point-of-care testing - Market size and forecast 2023-2028 ($ million)
Exhibits 55: Data Table on Point-of-care testing - Market size and forecast 2023-2028 ($ million)
Exhibits 56: Chart on Point-of-care testing - Year-over-year growth 2023-2028 (%)
Exhibits 57: Data Table on Point-of-care testing - Year-over-year growth 2023-2028 (%)
Exhibits 58: Chart on Immunodiagnostics - Market size and forecast 2023-2028 ($ million)
Exhibits 59: Data Table on Immunodiagnostics - Market size and forecast 2023-2028 ($ million)
Exhibits 60: Chart on Immunodiagnostics - Year-over-year growth 2023-2028 (%)
Exhibits 61: Data Table on Immunodiagnostics - Year-over-year growth 2023-2028 (%)
Exhibits 62: Chart on Molecular diagnostics - Market size and forecast 2023-2028 ($ million)
Exhibits 63: Data Table on Molecular diagnostics - Market size and forecast 2023-2028 ($ million)
Exhibits 64: Chart on Molecular diagnostics - Year-over-year growth 2023-2028 (%)
Exhibits 65: Data Table on Molecular diagnostics - Year-over-year growth 2023-2028 (%)
Exhibits 66: Market opportunity by Type ($ million)
Exhibits 67: Data Table on Market opportunity by Type ($ million)
Exhibits 68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 69: Chart on Market share By Geographical Landscape2023-2028 (%)
Exhibits 70: Data Table on Market share By Geographical Landscape2023-2028 (%)
Exhibits 71: Chart on Geographic comparison
Exhibits 72: Data Table on Geographic comparison
Exhibits 73: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 74: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 75: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits 76: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits 77: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 78: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 79: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 80: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 81: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 82: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 83: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 84: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 85: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 86: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 87: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 88: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 89: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits 90: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits 91: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits 92: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits 93: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits 94: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits 95: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits 96: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits 97: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 98: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 99: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 100: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 101: Chart on France - Market size and forecast 2023-2028 ($ million)
Exhibits 102: Data Table on France - Market size and forecast 2023-2028 ($ million)
Exhibits 103: Chart on France - Year-over-year growth 2023-2028 (%)
Exhibits 104: Data Table on France - Year-over-year growth 2023-2028 (%)
Exhibits 105: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits 106: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits 107: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits 108: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits 109: Market opportunity By Geographical Landscape($ million)
Exhibits 110: Data Tables on Market opportunity By Geographical Landscape($ million)
Exhibits 111: Impact of drivers and challenges in 2023 and 2028
Exhibits 112: Overview on criticality of inputs and factors of differentiation
Exhibits 113: Overview on factors of disruption
Exhibits 114: Impact of key risks on business
Exhibits 115: Companies covered
Exhibits 116: Matrix on companies position and classification
Exhibits 117: Abbott Laboratories - Overview
Exhibits 118: Abbott Laboratories - Business segments
Exhibits 119: Abbott Laboratories - Key news
Exhibits 120: Abbott Laboratories - Key offerings
Exhibits 121: Abbott Laboratories - Segment focus
Exhibits 122: Becton Dickinson and Co. - Overview
Exhibits 123: Becton Dickinson and Co. - Business segments
Exhibits 124: Becton Dickinson and Co. - Key news
Exhibits 125: Becton Dickinson and Co. - Key offerings
Exhibits 126: Becton Dickinson and Co. - Segment focus
Exhibits 127: BICO Group AB - Overview
Exhibits 128: BICO Group AB - Business segments
Exhibits 129: BICO Group AB - Key news
Exhibits 130: BICO Group AB - Key offerings
Exhibits 131: BICO Group AB - Segment focus
Exhibits 132: Bio Rad Laboratories Inc. - Overview
Exhibits 133: Bio Rad Laboratories Inc. - Business segments
Exhibits 134: Bio Rad Laboratories Inc. - Key news
Exhibits 135: Bio Rad Laboratories Inc. - Key offerings
Exhibits 136: Bio Rad Laboratories Inc. - Segment focus
Exhibits 137: Biocartis NV - Overview
Exhibits 138: Biocartis NV - Product / Service
Exhibits 139: Biocartis NV - Key news
Exhibits 140: Biocartis NV - Key offerings
Exhibits 141: bioMerieux SA - Overview
Exhibits 142: bioMerieux SA - Product / Service
Exhibits 143: bioMerieux SA - Key news
Exhibits 144: bioMerieux SA - Key offerings
Exhibits 145: Danaher Corp. - Overview
Exhibits 146: Danaher Corp. - Business segments
Exhibits 147: Danaher Corp. - Key news
Exhibits 148: Danaher Corp. - Key offerings
Exhibits 149: Danaher Corp. - Segment focus
Exhibits 150: DiaSorin SpA - Overview
Exhibits 151: DiaSorin SpA - Business segments
Exhibits 152: DiaSorin SpA - Key news
Exhibits 153: DiaSorin SpA - Key offerings
Exhibits 154: DiaSorin SpA - Segment focus
Exhibits 155: F. Hoffmann La Roche Ltd. - Overview
Exhibits 156: F. Hoffmann La Roche Ltd. - Business segments
Exhibits 157: F. Hoffmann La Roche Ltd. - Key news
Exhibits 158: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits 159: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits 160: Hologic Inc. - Overview
Exhibits 161: Hologic Inc. - Business segments
Exhibits 162: Hologic Inc. - Key news
Exhibits 163: Hologic Inc. - Key offerings
Exhibits 164: Hologic Inc. - Segment focus
Exhibits 165: Princeton BioMeditech Corp. - Overview
Exhibits 166: Princeton BioMeditech Corp. - Product / Service
Exhibits 167: Princeton BioMeditech Corp. - Key offerings
Exhibits 168: Quidelortho Corp. - Overview
Exhibits 169: Quidelortho Corp. - Product / Service
Exhibits 170: Quidelortho Corp. - Key news
Exhibits 171: Quidelortho Corp. - Key offerings
Exhibits 172: Sd Biosensor Inc. - Overview
Exhibits 173: Sd Biosensor Inc. - Product / Service
Exhibits 174: Sd Biosensor Inc. - Key offerings
Exhibits 175: Siemens Healthineers AG - Overview
Exhibits 176: Siemens Healthineers AG - Business segments
Exhibits 177: Siemens Healthineers AG - Key news
Exhibits 178: Siemens Healthineers AG - Key offerings
Exhibits 179: Siemens Healthineers AG - Segment focus
Exhibits 180: Thermo Fisher Scientific Inc. - Overview
Exhibits 181: Thermo Fisher Scientific Inc. - Business segments
Exhibits 182: Thermo Fisher Scientific Inc. - Key news
Exhibits 183: Thermo Fisher Scientific Inc. - Key offerings
Exhibits 184: Thermo Fisher Scientific Inc. - Segment focus
Exhibits 185: Inclusions checklist
Exhibits 186: Exclusions checklist
Exhibits 187: Currency conversion rates for US$
Exhibits 188: Research methodology
Exhibits 189: Information sources
Exhibits 190: Data validation
Exhibits 191: Validation techniques employed for market sizing
Exhibits 192: Data synthesis
Exhibits 193: 360 degree market analysis
Exhibits 194: List of abbreviations

Executive Summary

The following companies are recognized as the key players in the global influenza diagnostics market: Abbott Laboratories, Becton Dickinson and Co., BICO Group AB, Bio Rad Laboratories Inc., Biocartis NV, bioMerieux SA, Danaher Corp., DiaSorin SpA, F. Hoffmann La Roche Ltd., Hologic Inc., Princeton BioMeditech Corp., QIAGEN NV, Quidelortho Corp., Response Biomedical Corp., SA Scientific Ltd., Sd Biosensor Inc., Sekisui Chemical Co. Ltd., Siemens Healthineers AG, Tecan Trading AG, and Thermo Fisher Scientific Inc..

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is rising approvals for influenza diagnostic products."

According to the report, one of the major drivers for this market is the rising incidence of influenza.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories
  • Becton Dickinson and Co.
  • BICO Group AB
  • Bio Rad Laboratories Inc.
  • Biocartis NV
  • bioMerieux SA
  • Danaher Corp.
  • DiaSorin SpA
  • F. Hoffmann La Roche Ltd.
  • Hologic Inc.
  • Princeton BioMeditech Corp.
  • QIAGEN NV
  • Quidelortho Corp.
  • Response Biomedical Corp.
  • SA Scientific Ltd.
  • Sd Biosensor Inc.
  • Sekisui Chemical Co. Ltd.
  • Siemens Healthineers AG
  • Tecan Trading AG
  • Thermo Fisher Scientific Inc.